Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses
Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previou...
Gespeichert in:
Veröffentlicht in: | Toxicology and applied pharmacology 2015-10, Vol.288 (1), p.63-73 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 73 |
---|---|
container_issue | 1 |
container_start_page | 63 |
container_title | Toxicology and applied pharmacology |
container_volume | 288 |
creator | Ma, Jane Mercer, Robert R. Barger, Mark Schwegler-Berry, Diane Cohen, Joel M. Demokritou, Philip Castranova, Vincent |
description | Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previous studies have shown that exposure of rats to nanoscale CeO2 by intratracheal instillation (IT) induces sustained pulmonary inflammation and fibrosis. In the present study, male Sprague–Dawley rats were exposed to CeO2 or CeO2 coated with a nano layer of amorphous SiO2 (aSiO2/CeO2) by a single IT and sacrificed at various times post-exposure to assess potential protective effects of the aSiO2 coating. The first acellular bronchoalveolar lavage (BAL) fluid and BAL cells were collected and analyzed from all exposed animals. At the low dose (0.15mg/kg), CeO2 but not aSiO2/CeO2 exposure induced inflammation. However, at the higher doses, both particles induced a dose-related inflammation, cytotoxicity, inflammatory cytokines, matrix metalloproteinase (MMP)-9, and tissue inhibitor of MMP at 1day post-exposure. Morphological analysis of lung showed an increased inflammation, surfactant and collagen fibers after CeO2 (high dose at 3.5mg/kg) treatment at 28days post-exposure. aSiO2 coating significantly reduced CeO2-induced inflammatory responses in the airspace and appeared to attenuate phospholipidosis and fibrosis. Energy dispersive X-ray spectroscopy analysis showed Ce and phosphorous (P) in all particle-exposed lungs, whereas Si was only detected in aSiO2/CeO2-exposed lungs up to 3days after exposure, suggesting that aSiO2 dissolved off the CeO2 core, and some of the CeO2 was transformed to CePO4 with time. These results demonstrate that aSiO2 coating reduce CeO2-induced inflammation, phospholipidosis and fibrosis.
•Both CeO2 and aSiO2/CeO2 particles were detected in the respective particle-exposed lungs.•The dissolution of aSiO2 coating from CeO2 particle core with time was demonstrated in the particle-exposed lungs.•aSiO2 coating significantly protected CeO2-induced pulmonary inflammatory responses.•aSiO2 coating showed a protective effect on CeO2-induced lung fibrosis. |
doi_str_mv | 10.1016/j.taap.2015.07.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4579046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X15300387</els_id><sourcerecordid>1751206185</sourcerecordid><originalsourceid>FETCH-LOGICAL-c582t-a9a5a5d8759fd5fc65efeed1601660210e0a822d35fda248404aa31b931872443</originalsourceid><addsrcrecordid>eNp9kU9rFTEUxYMo9ln9Ai4k4MbNjDeZJDMDIkipf6DQTQU3EtLkTl8eM8mYzBT77c3watFNV1ncc09-9xxCXjOoGTD1_lAvxsw1ByZraGtg_AnZMehVBU3TPCU7AMEqgO7HCXmR8wEAeiHYc3LCFWfQiH5Hfp4PA9ol0zhQM8U07-Oaafajt4baaBYfbmgM1GLy60Tjb--QBhPibNLi7YiZ-uBWi47O6zjFYNIdTZjnGDLml-TZYMaMr-7fU_L98_nV2dfq4vLLt7NPF5WVHV8q0xtppOta2Q9ODlZJHBAdU-VKBQUVwXScu0YOznDRCRDGNOy6b1jXciGaU_Lx6Duv1xM6i2FJZtRz8lPh0dF4_f8k-L2-ibdayLYHoYrB26NBzIvX2foF7d7GEEo2mnPVta1qi-rd_Tcp_loxL3ry2eI4moAlNs1ayTgo1ski5UepTTHnhMMDDAO9tacPemtPb-1paHVpryy9-feMh5W_dRXBh6MAS5i3HtOGiqGk79NG6qJ_zP8PjnetQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1751206185</pqid></control><display><type>article</type><title>Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ma, Jane ; Mercer, Robert R. ; Barger, Mark ; Schwegler-Berry, Diane ; Cohen, Joel M. ; Demokritou, Philip ; Castranova, Vincent</creator><creatorcontrib>Ma, Jane ; Mercer, Robert R. ; Barger, Mark ; Schwegler-Berry, Diane ; Cohen, Joel M. ; Demokritou, Philip ; Castranova, Vincent</creatorcontrib><description>Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previous studies have shown that exposure of rats to nanoscale CeO2 by intratracheal instillation (IT) induces sustained pulmonary inflammation and fibrosis. In the present study, male Sprague–Dawley rats were exposed to CeO2 or CeO2 coated with a nano layer of amorphous SiO2 (aSiO2/CeO2) by a single IT and sacrificed at various times post-exposure to assess potential protective effects of the aSiO2 coating. The first acellular bronchoalveolar lavage (BAL) fluid and BAL cells were collected and analyzed from all exposed animals. At the low dose (0.15mg/kg), CeO2 but not aSiO2/CeO2 exposure induced inflammation. However, at the higher doses, both particles induced a dose-related inflammation, cytotoxicity, inflammatory cytokines, matrix metalloproteinase (MMP)-9, and tissue inhibitor of MMP at 1day post-exposure. Morphological analysis of lung showed an increased inflammation, surfactant and collagen fibers after CeO2 (high dose at 3.5mg/kg) treatment at 28days post-exposure. aSiO2 coating significantly reduced CeO2-induced inflammatory responses in the airspace and appeared to attenuate phospholipidosis and fibrosis. Energy dispersive X-ray spectroscopy analysis showed Ce and phosphorous (P) in all particle-exposed lungs, whereas Si was only detected in aSiO2/CeO2-exposed lungs up to 3days after exposure, suggesting that aSiO2 dissolved off the CeO2 core, and some of the CeO2 was transformed to CePO4 with time. These results demonstrate that aSiO2 coating reduce CeO2-induced inflammation, phospholipidosis and fibrosis.
•Both CeO2 and aSiO2/CeO2 particles were detected in the respective particle-exposed lungs.•The dissolution of aSiO2 coating from CeO2 particle core with time was demonstrated in the particle-exposed lungs.•aSiO2 coating significantly protected CeO2-induced pulmonary inflammatory responses.•aSiO2 coating showed a protective effect on CeO2-induced lung fibrosis.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/j.taap.2015.07.012</identifier><identifier>PMID: 26210349</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; ANIMAL TISSUES ; Animals ; Anti-Inflammatory Agents - chemistry ; Anti-Inflammatory Agents - pharmacology ; Bronchoalveolar Lavage Fluid - chemistry ; CERIUM ; Cerium - chemistry ; Cerium - toxicity ; Cerium oxide, amorphous silica ; CERIUM OXIDES ; CERIUM PHOSPHATES ; COLLAGEN ; Collagen - metabolism ; COMBUSTION ; CONSUMER PRODUCTS ; Cytokines - metabolism ; Cytoprotection ; DIESEL FUELS ; Dose-Response Relationship, Drug ; FIBROSIS ; FUEL ADDITIVES ; INFLAMMATION ; Inflammation Mediators - metabolism ; Lung - drug effects ; Lung - metabolism ; Lung - pathology ; Lung inflammation ; LUNGS ; LYMPHOKINES ; Male ; Matrix Metalloproteinase 9 - metabolism ; Metal Nanoparticles - chemistry ; Metal Nanoparticles - toxicity ; NANOPARTICLES ; Phospholipids - metabolism ; Pneumonia - chemically induced ; Pneumonia - metabolism ; Pneumonia - pathology ; Pneumonia - prevention & control ; Pulmonary fibrosis ; Pulmonary Fibrosis - chemically induced ; Pulmonary Fibrosis - metabolism ; Pulmonary Fibrosis - pathology ; Pulmonary Fibrosis - prevention & control ; Pulmonary Surfactant-Associated Proteins - metabolism ; RATS ; Rats, Sprague-Dawley ; Safer by design ; SILICA ; Silicon Dioxide - chemistry ; Silicon Dioxide - pharmacology ; SILICON OXIDES ; SOOT ; Spectrometry, X-Ray Emission ; Surface Properties ; Time Factors ; Tissue Inhibitor of Metalloproteinases - metabolism ; X-RAY SPECTROSCOPY</subject><ispartof>Toxicology and applied pharmacology, 2015-10, Vol.288 (1), p.63-73</ispartof><rights>2015</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c582t-a9a5a5d8759fd5fc65efeed1601660210e0a822d35fda248404aa31b931872443</citedby><cites>FETCH-LOGICAL-c582t-a9a5a5d8759fd5fc65efeed1601660210e0a822d35fda248404aa31b931872443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.taap.2015.07.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26210349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/22687767$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Jane</creatorcontrib><creatorcontrib>Mercer, Robert R.</creatorcontrib><creatorcontrib>Barger, Mark</creatorcontrib><creatorcontrib>Schwegler-Berry, Diane</creatorcontrib><creatorcontrib>Cohen, Joel M.</creatorcontrib><creatorcontrib>Demokritou, Philip</creatorcontrib><creatorcontrib>Castranova, Vincent</creatorcontrib><title>Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previous studies have shown that exposure of rats to nanoscale CeO2 by intratracheal instillation (IT) induces sustained pulmonary inflammation and fibrosis. In the present study, male Sprague–Dawley rats were exposed to CeO2 or CeO2 coated with a nano layer of amorphous SiO2 (aSiO2/CeO2) by a single IT and sacrificed at various times post-exposure to assess potential protective effects of the aSiO2 coating. The first acellular bronchoalveolar lavage (BAL) fluid and BAL cells were collected and analyzed from all exposed animals. At the low dose (0.15mg/kg), CeO2 but not aSiO2/CeO2 exposure induced inflammation. However, at the higher doses, both particles induced a dose-related inflammation, cytotoxicity, inflammatory cytokines, matrix metalloproteinase (MMP)-9, and tissue inhibitor of MMP at 1day post-exposure. Morphological analysis of lung showed an increased inflammation, surfactant and collagen fibers after CeO2 (high dose at 3.5mg/kg) treatment at 28days post-exposure. aSiO2 coating significantly reduced CeO2-induced inflammatory responses in the airspace and appeared to attenuate phospholipidosis and fibrosis. Energy dispersive X-ray spectroscopy analysis showed Ce and phosphorous (P) in all particle-exposed lungs, whereas Si was only detected in aSiO2/CeO2-exposed lungs up to 3days after exposure, suggesting that aSiO2 dissolved off the CeO2 core, and some of the CeO2 was transformed to CePO4 with time. These results demonstrate that aSiO2 coating reduce CeO2-induced inflammation, phospholipidosis and fibrosis.
•Both CeO2 and aSiO2/CeO2 particles were detected in the respective particle-exposed lungs.•The dissolution of aSiO2 coating from CeO2 particle core with time was demonstrated in the particle-exposed lungs.•aSiO2 coating significantly protected CeO2-induced pulmonary inflammatory responses.•aSiO2 coating showed a protective effect on CeO2-induced lung fibrosis.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>ANIMAL TISSUES</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>CERIUM</subject><subject>Cerium - chemistry</subject><subject>Cerium - toxicity</subject><subject>Cerium oxide, amorphous silica</subject><subject>CERIUM OXIDES</subject><subject>CERIUM PHOSPHATES</subject><subject>COLLAGEN</subject><subject>Collagen - metabolism</subject><subject>COMBUSTION</subject><subject>CONSUMER PRODUCTS</subject><subject>Cytokines - metabolism</subject><subject>Cytoprotection</subject><subject>DIESEL FUELS</subject><subject>Dose-Response Relationship, Drug</subject><subject>FIBROSIS</subject><subject>FUEL ADDITIVES</subject><subject>INFLAMMATION</subject><subject>Inflammation Mediators - metabolism</subject><subject>Lung - drug effects</subject><subject>Lung - metabolism</subject><subject>Lung - pathology</subject><subject>Lung inflammation</subject><subject>LUNGS</subject><subject>LYMPHOKINES</subject><subject>Male</subject><subject>Matrix Metalloproteinase 9 - metabolism</subject><subject>Metal Nanoparticles - chemistry</subject><subject>Metal Nanoparticles - toxicity</subject><subject>NANOPARTICLES</subject><subject>Phospholipids - metabolism</subject><subject>Pneumonia - chemically induced</subject><subject>Pneumonia - metabolism</subject><subject>Pneumonia - pathology</subject><subject>Pneumonia - prevention & control</subject><subject>Pulmonary fibrosis</subject><subject>Pulmonary Fibrosis - chemically induced</subject><subject>Pulmonary Fibrosis - metabolism</subject><subject>Pulmonary Fibrosis - pathology</subject><subject>Pulmonary Fibrosis - prevention & control</subject><subject>Pulmonary Surfactant-Associated Proteins - metabolism</subject><subject>RATS</subject><subject>Rats, Sprague-Dawley</subject><subject>Safer by design</subject><subject>SILICA</subject><subject>Silicon Dioxide - chemistry</subject><subject>Silicon Dioxide - pharmacology</subject><subject>SILICON OXIDES</subject><subject>SOOT</subject><subject>Spectrometry, X-Ray Emission</subject><subject>Surface Properties</subject><subject>Time Factors</subject><subject>Tissue Inhibitor of Metalloproteinases - metabolism</subject><subject>X-RAY SPECTROSCOPY</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9rFTEUxYMo9ln9Ai4k4MbNjDeZJDMDIkipf6DQTQU3EtLkTl8eM8mYzBT77c3watFNV1ncc09-9xxCXjOoGTD1_lAvxsw1ByZraGtg_AnZMehVBU3TPCU7AMEqgO7HCXmR8wEAeiHYc3LCFWfQiH5Hfp4PA9ol0zhQM8U07-Oaafajt4baaBYfbmgM1GLy60Tjb--QBhPibNLi7YiZ-uBWi47O6zjFYNIdTZjnGDLml-TZYMaMr-7fU_L98_nV2dfq4vLLt7NPF5WVHV8q0xtppOta2Q9ODlZJHBAdU-VKBQUVwXScu0YOznDRCRDGNOy6b1jXciGaU_Lx6Duv1xM6i2FJZtRz8lPh0dF4_f8k-L2-ibdayLYHoYrB26NBzIvX2foF7d7GEEo2mnPVta1qi-rd_Tcp_loxL3ry2eI4moAlNs1ayTgo1ski5UepTTHnhMMDDAO9tacPemtPb-1paHVpryy9-feMh5W_dRXBh6MAS5i3HtOGiqGk79NG6qJ_zP8PjnetQg</recordid><startdate>20151001</startdate><enddate>20151001</enddate><creator>Ma, Jane</creator><creator>Mercer, Robert R.</creator><creator>Barger, Mark</creator><creator>Schwegler-Berry, Diane</creator><creator>Cohen, Joel M.</creator><creator>Demokritou, Philip</creator><creator>Castranova, Vincent</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>OTOTI</scope><scope>5PM</scope></search><sort><creationdate>20151001</creationdate><title>Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses</title><author>Ma, Jane ; Mercer, Robert R. ; Barger, Mark ; Schwegler-Berry, Diane ; Cohen, Joel M. ; Demokritou, Philip ; Castranova, Vincent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c582t-a9a5a5d8759fd5fc65efeed1601660210e0a822d35fda248404aa31b931872443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>ANIMAL TISSUES</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>CERIUM</topic><topic>Cerium - chemistry</topic><topic>Cerium - toxicity</topic><topic>Cerium oxide, amorphous silica</topic><topic>CERIUM OXIDES</topic><topic>CERIUM PHOSPHATES</topic><topic>COLLAGEN</topic><topic>Collagen - metabolism</topic><topic>COMBUSTION</topic><topic>CONSUMER PRODUCTS</topic><topic>Cytokines - metabolism</topic><topic>Cytoprotection</topic><topic>DIESEL FUELS</topic><topic>Dose-Response Relationship, Drug</topic><topic>FIBROSIS</topic><topic>FUEL ADDITIVES</topic><topic>INFLAMMATION</topic><topic>Inflammation Mediators - metabolism</topic><topic>Lung - drug effects</topic><topic>Lung - metabolism</topic><topic>Lung - pathology</topic><topic>Lung inflammation</topic><topic>LUNGS</topic><topic>LYMPHOKINES</topic><topic>Male</topic><topic>Matrix Metalloproteinase 9 - metabolism</topic><topic>Metal Nanoparticles - chemistry</topic><topic>Metal Nanoparticles - toxicity</topic><topic>NANOPARTICLES</topic><topic>Phospholipids - metabolism</topic><topic>Pneumonia - chemically induced</topic><topic>Pneumonia - metabolism</topic><topic>Pneumonia - pathology</topic><topic>Pneumonia - prevention & control</topic><topic>Pulmonary fibrosis</topic><topic>Pulmonary Fibrosis - chemically induced</topic><topic>Pulmonary Fibrosis - metabolism</topic><topic>Pulmonary Fibrosis - pathology</topic><topic>Pulmonary Fibrosis - prevention & control</topic><topic>Pulmonary Surfactant-Associated Proteins - metabolism</topic><topic>RATS</topic><topic>Rats, Sprague-Dawley</topic><topic>Safer by design</topic><topic>SILICA</topic><topic>Silicon Dioxide - chemistry</topic><topic>Silicon Dioxide - pharmacology</topic><topic>SILICON OXIDES</topic><topic>SOOT</topic><topic>Spectrometry, X-Ray Emission</topic><topic>Surface Properties</topic><topic>Time Factors</topic><topic>Tissue Inhibitor of Metalloproteinases - metabolism</topic><topic>X-RAY SPECTROSCOPY</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Jane</creatorcontrib><creatorcontrib>Mercer, Robert R.</creatorcontrib><creatorcontrib>Barger, Mark</creatorcontrib><creatorcontrib>Schwegler-Berry, Diane</creatorcontrib><creatorcontrib>Cohen, Joel M.</creatorcontrib><creatorcontrib>Demokritou, Philip</creatorcontrib><creatorcontrib>Castranova, Vincent</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>OSTI.GOV</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Jane</au><au>Mercer, Robert R.</au><au>Barger, Mark</au><au>Schwegler-Berry, Diane</au><au>Cohen, Joel M.</au><au>Demokritou, Philip</au><au>Castranova, Vincent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2015-10-01</date><risdate>2015</risdate><volume>288</volume><issue>1</issue><spage>63</spage><epage>73</epage><pages>63-73</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><abstract>Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previous studies have shown that exposure of rats to nanoscale CeO2 by intratracheal instillation (IT) induces sustained pulmonary inflammation and fibrosis. In the present study, male Sprague–Dawley rats were exposed to CeO2 or CeO2 coated with a nano layer of amorphous SiO2 (aSiO2/CeO2) by a single IT and sacrificed at various times post-exposure to assess potential protective effects of the aSiO2 coating. The first acellular bronchoalveolar lavage (BAL) fluid and BAL cells were collected and analyzed from all exposed animals. At the low dose (0.15mg/kg), CeO2 but not aSiO2/CeO2 exposure induced inflammation. However, at the higher doses, both particles induced a dose-related inflammation, cytotoxicity, inflammatory cytokines, matrix metalloproteinase (MMP)-9, and tissue inhibitor of MMP at 1day post-exposure. Morphological analysis of lung showed an increased inflammation, surfactant and collagen fibers after CeO2 (high dose at 3.5mg/kg) treatment at 28days post-exposure. aSiO2 coating significantly reduced CeO2-induced inflammatory responses in the airspace and appeared to attenuate phospholipidosis and fibrosis. Energy dispersive X-ray spectroscopy analysis showed Ce and phosphorous (P) in all particle-exposed lungs, whereas Si was only detected in aSiO2/CeO2-exposed lungs up to 3days after exposure, suggesting that aSiO2 dissolved off the CeO2 core, and some of the CeO2 was transformed to CePO4 with time. These results demonstrate that aSiO2 coating reduce CeO2-induced inflammation, phospholipidosis and fibrosis.
•Both CeO2 and aSiO2/CeO2 particles were detected in the respective particle-exposed lungs.•The dissolution of aSiO2 coating from CeO2 particle core with time was demonstrated in the particle-exposed lungs.•aSiO2 coating significantly protected CeO2-induced pulmonary inflammatory responses.•aSiO2 coating showed a protective effect on CeO2-induced lung fibrosis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26210349</pmid><doi>10.1016/j.taap.2015.07.012</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-008X |
ispartof | Toxicology and applied pharmacology, 2015-10, Vol.288 (1), p.63-73 |
issn | 0041-008X 1096-0333 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4579046 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | 60 APPLIED LIFE SCIENCES ANIMAL TISSUES Animals Anti-Inflammatory Agents - chemistry Anti-Inflammatory Agents - pharmacology Bronchoalveolar Lavage Fluid - chemistry CERIUM Cerium - chemistry Cerium - toxicity Cerium oxide, amorphous silica CERIUM OXIDES CERIUM PHOSPHATES COLLAGEN Collagen - metabolism COMBUSTION CONSUMER PRODUCTS Cytokines - metabolism Cytoprotection DIESEL FUELS Dose-Response Relationship, Drug FIBROSIS FUEL ADDITIVES INFLAMMATION Inflammation Mediators - metabolism Lung - drug effects Lung - metabolism Lung - pathology Lung inflammation LUNGS LYMPHOKINES Male Matrix Metalloproteinase 9 - metabolism Metal Nanoparticles - chemistry Metal Nanoparticles - toxicity NANOPARTICLES Phospholipids - metabolism Pneumonia - chemically induced Pneumonia - metabolism Pneumonia - pathology Pneumonia - prevention & control Pulmonary fibrosis Pulmonary Fibrosis - chemically induced Pulmonary Fibrosis - metabolism Pulmonary Fibrosis - pathology Pulmonary Fibrosis - prevention & control Pulmonary Surfactant-Associated Proteins - metabolism RATS Rats, Sprague-Dawley Safer by design SILICA Silicon Dioxide - chemistry Silicon Dioxide - pharmacology SILICON OXIDES SOOT Spectrometry, X-Ray Emission Surface Properties Time Factors Tissue Inhibitor of Metalloproteinases - metabolism X-RAY SPECTROSCOPY |
title | Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T20%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20amorphous%20silica%20coating%20on%20cerium%20oxide%20nanoparticles%20induced%20pulmonary%20responses&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Ma,%20Jane&rft.date=2015-10-01&rft.volume=288&rft.issue=1&rft.spage=63&rft.epage=73&rft.pages=63-73&rft.issn=0041-008X&rft.eissn=1096-0333&rft_id=info:doi/10.1016/j.taap.2015.07.012&rft_dat=%3Cproquest_pubme%3E1751206185%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1751206185&rft_id=info:pmid/26210349&rft_els_id=S0041008X15300387&rfr_iscdi=true |